title: Pharmacokinetic comparison of orally-disintegrating metoclopramide with conventional metoclopramide tablet formulation in healthy volunteers.
abstract: BACKGROUND
  Oral tablet formulations of metoclopramide are effective therapies for gastroparesis and gastro-oesophageal reflux disease; however, difficulty swallowing tablets or nausea/vomiting may reduce patient adherence to therapy. Because of this, a metoclopramide orally-disintegrating tablet (ODT) has been developed.
  
  
  OBJECTIVE
  To evaluate the bioequivalence of a single administration of a 10-mg metoclopramide ODT and a conventional 10-mg oral metoclopramide tablet in healthy volunteers.
  
  
  METHODS
  In a randomized, single-dose, crossover study, healthy volunteers received single administration of 10-mg metoclopramide ODT and 10-mg conventional metoclopramide tablet, with a 7-day interval between treatments. Serial blood samples were collected before dosing and during 24 h post-treatment.
  
  
  RESULTS
  Forty-one volunteers completed both treatment arms. Metoclopramide ODT was bioequivalent to conventional tablets; 90% CIs for geometric mean treatment ratios of C(max) [91.6% (90% CI, 87.7-95.8%)], AUC(last) [97.3% (90% CI, 94.5-100.2%)] and AUC(inf) [97.6% (90% CI, 94.5-100.8%)] were within the predefined range. Of the 44 volunteers included in the safety analysis, 9 (20%) reported AEs after ODT, compared with 13 (30%) after conventional tablets.
  
  
  CONCLUSIONS
  In healthy volunteers, single administration of 10-mg metoclopramide ODT was well tolerated and bioequivalent to single administration of a conventional 10-mg metoclopramide tablet.
authors.affiliation: University of Arizona Health Science Center, Tucson, AZ, USA.
authors.forename: R
authors.initials: R
authors.lastname: Fass
authors.forename: H J
authors.initials: HJ
authors.lastname: Pieniaszek
authors.forename: J R
authors.initials: JR
authors.lastname: Thompson
mesh_terms: D000284:Administration, Oral; D000293:Adolescent; D000328:Adult; D018592:Cross-Over Studies; D003680:Deglutition Disorders; D005260:Female; D005764:Gastroesophageal Reflux / Q000188:drug therapy*; D006801:Humans; D008297:Male; D055118:Medication Adherence; D008787:Metoclopramide / Q000008:administration & dosage / Q000493:pharmacokinetics*; D008875:Middle Aged; D013607:Tablets; D013810:Therapeutic Equivalency; D055815:Young Adult
chemical_list: D013607:Tablets; D008787:Metoclopramide